Callan Family Office LLC Takes Position in HealthEquity, Inc. $HQY

Callan Family Office LLC purchased a new stake in HealthEquity, Inc. (NASDAQ:HQY) in the 2nd quarter, HoldingsChannel.com reports. The fund purchased 7,954 shares of the company’s stock, valued at approximately $718,000.

A number of other large investors have also recently bought and sold shares of HQY. Acumen Wealth Advisors LLC purchased a new position in HealthEquity during the 4th quarter worth $27,000. Caitong International Asset Management Co. Ltd raised its holdings in shares of HealthEquity by 1,723.5% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after buying an additional 293 shares during the last quarter. Aster Capital Management DIFC Ltd acquired a new stake in shares of HealthEquity during the fourth quarter worth about $28,000. Leonteq Securities AG boosted its stake in shares of HealthEquity by 159.9% during the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock worth $32,000 after buying an additional 235 shares during the period. Finally, Axiom Investment Management LLC purchased a new position in shares of HealthEquity during the first quarter worth about $33,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

Analysts Set New Price Targets

HQY has been the topic of several recent research reports. Barrington Research restated an “outperform” rating and issued a $110.00 price target on shares of HealthEquity in a research report on Friday, May 22nd. Wall Street Zen raised HealthEquity from a “hold” rating to a “buy” rating in a research report on Saturday. Citizens Jmp lifted their target price on HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a research note on Monday, June 1st. Weiss Ratings upgraded HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 5th. Finally, Wells Fargo & Company set a $111.00 price target on HealthEquity in a report on Monday, June 1st. Eleven research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $110.93.

Insider Transactions at HealthEquity

In related news, EVP Delano Ladd sold 7,500 shares of HealthEquity stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the sale, the executive vice president directly owned 91,141 shares in the company, valued at $8,202,690. The trade was a 7.60% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the company’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the transaction, the director directly owned 19,733 shares in the company, valued at $1,775,970. This represents a 11.00% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 17,905 shares of company stock valued at $1,651,280. Corporate insiders own 1.60% of the company’s stock.

HealthEquity Trading Down 0.0%

Shares of HealthEquity stock opened at $105.39 on Wednesday. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $107.62. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46. The company’s 50-day simple moving average is $97.41 and its 200-day simple moving average is $87.53. The firm has a market cap of $8.81 billion, a price-to-earnings ratio of 39.47, a price-to-earnings-growth ratio of 1.77 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.13. The firm had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The firm’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, equities research analysts anticipate that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.